Prof. Bianca JJM Brundel received her Ph.D. from the University Medical Center Groningen, the Netherlands, and was trained in molecular and cellular biology (VU, Amsterdam) and clinical pharmacology (UMCG). Since 2016, she has been a Professor in the Physiology Department at the Amsterdam UMC, located at the VU University Medical Center. Her research is focused on the molecular mechanisms driving proteostasis derailment and the pathophysiology of cardiac diseases, including atrial fibrillation and cardiomyopathies. Her laboratory utilizes experimental cardiomyocyte and Drosophila cardiac disease models in combination with genetic and pharmacological manipulations. She is the project leader for several translational research projects and founder of the Atrial Fibrillation Innovation Platform, which aims to promote translational studies in collaboration with patients, and the Cardiac Arrhythmia Lab, aiming to develop bio-electrical diagnostic tools. The research of Prof. Brundel has contributed to forwarding candidate drugs into (pre-)clinical proof-of-principle studies. Moreover, she is the lead author of the Nature Disease Primer ‘Atrial Fibrillation’, together with Mellanie True Hills and others.